Treatment of Dissociative Identity Disorder (DID)
There is no FDA-approved medication specifically for DID, and psychotherapy—not medication—is the primary evidence-based treatment for this condition. Medications should only target comorbid symptoms such as depression, anxiety, or PTSD that commonly accompany DID, while trauma-focused psychotherapy addresses the core dissociative pathology 1, 2, 3.
Primary Treatment Approach
Phase-oriented psychotherapy is the cornerstone of DID treatment, typically progressing through three stages: symptom stabilization and safety, trauma processing, and identity integration/rehabilitation 1, 2.
- Schema Therapy has emerged as a promising evidence-based approach for DID, demonstrating reductions in dissociative symptoms, PTSD symptoms, and improvements in functioning in recent case studies 4, 5.
- Traditional psychodynamic approaches remain widely practiced, though treatment duration is lengthy (often years) and dropout rates can be high 1, 5.
- Trauma processing through techniques like Imagery Rescripting can be integrated once stabilization is achieved 4.
Pharmacological Management of Comorbid Symptoms
Since your patient is experiencing overwhelm related to divorce, medication may help manage acute distress symptoms, but medication should never be the sole intervention 2, 3.
For Depression and Anxiety Symptoms:
- SSRIs (sertraline or fluoxetine) are first-line agents for treating comorbid depression and anxiety in trauma-exposed populations 6.
- Start sertraline at 25-50mg daily and titrate slowly, as trauma survivors may have heightened medication sensitivity 7.
- Avoid benzodiazepines for chronic anxiety management due to risks of disinhibition, dependence, and potential worsening of dissociative symptoms 6.
For Acute Distress and Sleep:
- Mirtazapine offers dual benefits of treating depression while providing sedation and appetite stimulation, which may be helpful during acute stress periods 6.
- Melatonin or melatonin receptor agonists (ramelteon) are preferred over benzodiazepine hypnotics for sleep disturbances 6.
- Avoid zolpidem and eszopiclone due to cognitive impairment risks and potential to worsen dissociative symptoms 6.
Medications to Avoid:
- Tricyclic antidepressants and MAO inhibitors have significant side effect profiles and should be avoided 6.
- Antipsychotics are not indicated unless there are comorbid psychotic symptoms or severe behavioral dyscontrol 6.
- Benzodiazepines should be avoided for chronic use due to disinhibition risk and potential to interfere with trauma processing 6.
Critical Treatment Considerations
Common pitfalls to avoid:
- Do not prescribe medication as monotherapy for DID—this violates evidence-based practice and fails to address the core dissociative pathology 2, 3.
- Screen for trauma history and ongoing safety concerns before initiating any treatment, as individuals with DID have elevated victimization risk 7.
- Assess for other psychiatric comorbidities (PTSD, depression, anxiety disorders, substance use) that require concurrent treatment 2, 3.
- Recognize that dissociative symptoms may worsen initially during trauma processing phases of therapy 1, 4.
Practical Treatment Algorithm
Step 1: Establish safety and stabilization through supportive psychotherapy while assessing for immediate suicide risk, self-harm, or dangerous situations 1, 2.
Step 2: If significant depression or anxiety symptoms are present (as suggested by "overwhelmed"), initiate sertraline 25-50mg daily, titrating to 100-200mg as tolerated 6, 7.
Step 3: Refer to a trauma-specialized therapist experienced in treating dissociative disorders, preferably with training in Schema Therapy or phase-oriented treatment for DID 4, 5, 3.
Step 4: Address sleep disturbances with melatonin 3-10mg at bedtime or consider mirtazapine 7.5-15mg if depression and insomnia coexist 6.
Step 5: Monitor medication response at 2-4 week intervals, but recognize that psychotherapy effects will take months to manifest and treatment duration typically spans 2-3 years 1, 4, 5.
Specialized Referral
Refer to psychiatrists or psychologists specializing in dissociative disorders for treatment-refractory cases or when diagnostic uncertainty exists 7, 3. The International Society for the Study of Trauma and Dissociation maintains a referral directory of specialized clinicians 3.